Both in Biotechnology
LENZ Therapeutics vs Anavex Life Sciences
Over the past year LENZ returned −87.5% and AVXL returned −84.5%; their daily moves had a correlation of 0.24.
LENZ −87.5% AVXL −84.5%Growth of $1, one year, split-adjusted
| Metric | LENZ | AVXL |
|---|---|---|
| Price | $3.50 | $1.20 |
| Market cap | $110.0M | $111.2M |
| Today | +14.75% | +5.26% |
| 1 month | −2.5% | −27.1% |
| 6 months | −61.4% | −64.3% |
| Year to date | −78.1% | −66.3% |
| 1 year | −88.2% | −84.9% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 94.9% | — |
| Net margin | −581.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.1× | — |
| Net cash | $220.0M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.0% | 74.0% |
| Short % of float | 46.7% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).